Encouraging results with the compassionate use of hydralazine/valproate (TRANSKRIP™) as epigenetic treatment for myelodysplastic syndrome (MDS)
Crossref DOI link: https://doi.org/10.1007/s00277-017-3103-x
Published Online: 2017-08-23
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Candelaria, Myrna http://orcid.org/0000-0002-5478-714X
Burgos, Sebastian
Ponce, Mayra
Espinoza, Ramiro
Dueñas-Gonzalez, Alfonso
License valid from 2017-08-23